2839 related articles for article (PubMed ID: 7691728)
1. Morphological, phenotypic and functional characteristics of a pure population of CD56+ CD16- CD3- large granular lymphocytes generated from human duodenal mucosa.
Pang G; Buret A; Batey RT; Chen QY; Couch L; Cripps A; Clancy R
Immunology; 1993 Jul; 79(3):498-505. PubMed ID: 7691728
[TBL] [Abstract][Full Text] [Related]
2. In vitro responsiveness to interleukins and theophylline of CD16+, CD56- natural killer cells in a patient with chronic granular lymphocyte disorder.
Bayle C; Vitté-Mony I; Lang P; Pico J; Hercend T; Bertoglio J
Leukemia; 1992 May; 6(5):470-6. PubMed ID: 1375700
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
[TBL] [Abstract][Full Text] [Related]
4. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
Gaddy J; Broxmeyer HE
Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic and functional analysis of human CD3- decidual leucocyte clones.
Christmas SE; Bulmer JN; Meager A; Johnson PM
Immunology; 1990 Oct; 71(2):182-9. PubMed ID: 2146213
[TBL] [Abstract][Full Text] [Related]
6. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
[TBL] [Abstract][Full Text] [Related]
7. A novel large granular lymphocyte-like cell isolated from IL-2-supplemented murine intestinal lamina propria lymphocyte cultures with potent inhibitory action on lymphocyte proliferation.
Hörnqvist E; Enerbäck L; Chen XJ; Lycke N
Cell Immunol; 1993 Apr; 148(1):71-90. PubMed ID: 8495492
[TBL] [Abstract][Full Text] [Related]
8. The CD56 adhesion molecule is the major determinant for detecting non-major histocompatibility complex-restricted cytotoxic mononuclear cells from the intestinal lamina propria.
Van Tol EA; Verspaget HW; Peña AS; Kraemer CV; Lamers CB
Eur J Immunol; 1992 Jan; 22(1):23-9. PubMed ID: 1370415
[TBL] [Abstract][Full Text] [Related]
9. Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes.
Ferry BL; Starkey PM; Sargent IL; Watt GM; Jackson M; Redman CW
Immunology; 1990 Aug; 70(4):446-52. PubMed ID: 1697563
[TBL] [Abstract][Full Text] [Related]
10. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
[TBL] [Abstract][Full Text] [Related]
11. Expression of adhesion molecules by human decidual large granular lymphocytes.
Burrows TD; King A; Loke YW
Cell Immunol; 1993 Mar; 147(1):81-94. PubMed ID: 7681732
[TBL] [Abstract][Full Text] [Related]
12. Promotion of natural killer cell growth in vitro by bispecific (anti-CD3 x anti-CD16) antibodies.
Malygin AM; Somersalo K; Timonen T
Immunology; 1994 Jan; 81(1):92-5. PubMed ID: 7510664
[TBL] [Abstract][Full Text] [Related]
13. Lymphokine-activated killing by human intestinal lymphocytes.
Ebert EC; Roberts AI
Cell Immunol; 1993 Jan; 146(1):107-16. PubMed ID: 7678783
[TBL] [Abstract][Full Text] [Related]
14. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
[TBL] [Abstract][Full Text] [Related]
15. Clinical and immunological effects of granulocyte-macrophage colony-stimulating factor coadministered with interleukin 2: a phase IB study.
Schiller JH; Hank JA; Khorsand M; Storer B; Borchert A; Huseby-Moore K; Burns D; Wesly O; Albertini MR; Wilding G; Sondel PM
Clin Cancer Res; 1996 Feb; 2(2):319-30. PubMed ID: 9816175
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a human cell line (NK-92) with phenotypical and functional characteristics of activated natural killer cells.
Gong JH; Maki G; Klingemann HG
Leukemia; 1994 Apr; 8(4):652-8. PubMed ID: 8152260
[TBL] [Abstract][Full Text] [Related]
17. The effect of interleukin 2 and transforming growth factor-beta 2 (TGF-beta 2) on the proliferation and natural killer activity of decidual CD16- CD56bright natural killer cells.
Saito S; Morii T; Enomoto M; Sakakura S; Nishikawa K; Narita N; Ichijo M
Cell Immunol; 1993 Dec; 152(2):605-13. PubMed ID: 7504983
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes.
Smyth MJ; Ortaldo JR
J Immunol; 1991 Feb; 146(4):1380-4. PubMed ID: 1991975
[TBL] [Abstract][Full Text] [Related]
19. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns.
Doherty DG; Norris S; Madrigal-Estebas L; McEntee G; Traynor O; Hegarty JE; O'Farrelly C
J Immunol; 1999 Aug; 163(4):2314-21. PubMed ID: 10438977
[TBL] [Abstract][Full Text] [Related]
20. Genesis of human oncolytic natural killer cells from primitive CD34+CD33- bone marrow progenitors.
Lotzová E; Savary CA; Champlin RE
J Immunol; 1993 Jun; 150(12):5263-9. PubMed ID: 7685792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
